Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Depression

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Depression in 2 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Sales, AJ1
Joca, SRL1
Del Bel, E1
GuimarĂ£es, FS1
da Silva Leal, VM1
Bonassoli, VT1
Soares, LM1
Milani, H1
de Oliveira, RMW1

Other Studies

2 other studies available for n-(3-(aminomethyl)benzyl)acetamidine and Depression

ArticleYear
The antidepressant-like effect of doxycycline is associated with decreased nitric oxide metabolite levels in the prefrontal cortex.
    Behavioural brain research, 2024, Feb-26, Volume: 458

    Topics: Animals; Antidepressive Agents; Depression; Doxycycline; Male; Mice; Nitric Oxide; Prefrontal Cortex

2024
Depletion of 5 hydroxy-triptamine (5-HT) affects the antidepressant-like effect of neuronal nitric oxide synthase inhibitor in mice.
    Neuroscience letters, 2017, Aug-24, Volume: 656

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Dose-Response Relationship, Drug; Drug

2017